|
34
|
180
|
2zu3A |
Complex structure of cvb3 3c protease with tg-0204998 |
|
35
|
180
|
2ztzA |
Crystal structure of 3c protease from cvb3 in space group p21 |
|
35
|
180
|
2ztxA |
Complex structure of cvb3 3c protease with epdtc |
|
34
|
180
|
2ztyA |
Crystal structure of 3c protease from cvb3 in space group c2 |
|
39
|
182
|
2xyaA |
Non-covalent inhibtors of rhinovirus 3c protease. |
|
43
|
200
|
2wv5A |
Crystal structure of foot-and-mouth disease virus 3c protease in complex with a decameric peptide corresponding to the vp1-2a cleavage junction with a gln to glu substitution at p1 |
|
44
|
201
|
2wv4A |
Crystal structure of foot-and-mouth disease virus 3c protease in complex with a decameric peptide corresponding to the vp1-2a cleavage junction |
|
35
|
183
|
2vb0A |
Crystal structure of coxsackievirus b3 proteinase 3c |
|
2
|
40
|
2rs54 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
42
|
273
|
2rs11 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
38
|
236
|
2rmu3 |
Three-dimensional structures of drug-resistant mutants of human rhinovirus 14 |
|
47
|
255
|
2rs52 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
2
|
40
|
2rs34 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
2
|
40
|
2rr14 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
2
|
40
|
2rs14 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
37
|
236
|
2rs33 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
44
|
273
|
2rs31 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
47
|
255
|
2rmu2 |
Three-dimensional structures of drug-resistant mutants of human rhinovirus 14 |
|
47
|
255
|
2rs32 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
47
|
255
|
2rm22 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
43
|
273
|
2rs51 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
47
|
273
|
2rmu1 |
Three-dimensional structures of drug-resistant mutants of human rhinovirus 14 |
|
2
|
40
|
2rm24 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
47
|
255
|
2rs12 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
2
|
40
|
2rmu4 |
Three-dimensional structures of drug-resistant mutants of human rhinovirus 14 |
|
43
|
273
|
2rm21 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
37
|
236
|
2rs53 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
47
|
255
|
2rr12 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
44
|
273
|
2rr11 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
37
|
236
|
2rs13 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
37
|
236
|
2rr13 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
37
|
236
|
2rm23 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
38
|
236
|
2r063 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
38
|
236
|
2r073 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
47
|
255
|
2r072 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
2
|
40
|
2r064 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
47
|
255
|
2r062 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
38
|
236
|
2r043 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
2
|
40
|
2r044 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
41
|
273
|
2r041 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
2
|
40
|
2r074 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
47
|
255
|
2r042 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
41
|
273
|
2r071 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
42
|
273
|
2r061 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
41
|
300
|
2plv1 |
Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus |
|
61
|
268
|
2plv2 |
Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus |
|
38
|
235
|
2plv3 |
Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus |
|
3
|
68
|
2plv4 |
Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus |
|
2
|
71
|
2m7yA |
The mengovirus leader protein |
|
3
|
71
|
2mmkA |
Y41 and t47 phosphorylation of the mengovirus leader protein: nmr studies of the phosphorylation of the mengovirus leader protein reveal stabilization of intermolecular domain interactions |
